Jaguar Health, Inc.: Jaguar Health Announces FDA Conditional Approval of Canalevia-CA1 (Crofelemer), the First and Only Treatment for Chemotherapy-Induced Diarrhea (CID) in Dogs to Receive Any Type of Approval from FDA
By prescription only, Canalevia-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based product sustainably harvested from the Croton lechleri treeSAN FRANCISCO, CA / ACCESSWIRE
United States Lisa Conte Peter Hodge Cancer In Pets American Veterinary Medical Association Jaguar Health National Cancer Institute
Source: finanznachrichten.de